Print Page   |   Sign In   |   Register
Newsletters
Blog Home All Blogs
Check out all our past newsletters here.

 

Search all posts for:   

 

Stock Market Manager Weekly Update: September 11th, 2019

Posted By Administration, Friday, September 13, 2019

SMM Logo

               

 

 

 

Weekly Update: September11th, 2019

http://www.valuengine.com/images/newsletter/weekly/facebook-icon-743200.jpg

http://www.valuengine.com/images/newsletter/weekly/TWITTERICON.jpg

http://ecomallymail.com/uploads/1524105419.png

6,462

520

472

6

11

 

 

Black Swan Connection Newsletter Signup


Breaking News

 

Reuters 9-12-19

Stocks Climb, bond yields off lows, on trade progress hopes

New York, Sept 12 (Reuters)- A gauge of stock markets touched its highest since late Thursday after fresh hints of progress in US-China trade dispute, sending bond yields off lows hit earlier in wake of the European Central Banks new stimulus measures.

Read Complete Report

 

9-4-19 Greenridge Global Equity Research Issues Updates
Guangdong Land Holdings, Ltd. HKSE 0124


Sales Continues At All Portfolio Properties

Unit Sales Continue Across Property Portfolio.  GDL reported first half results with Revenue of HK$464.1 million, which was generated from the delivery of 4,440m2 from Laurel House, 102m2 from Baohuaxuan, and 2,186m2 of residential space and 207m2 of car parking spaces at Ruyingju.  Pre-sales of GDH City during the period was 4,991m2.  Cost of Sales was HK$344.5 million, for a Gross Profit of HK$119.6 million, or 25.8%.  SG&A was HK$80.9 million, up significantly reflecting the greater number of projects GDL owns and increased marketing activity at GDH City.  Included in the marketing activities was a well-attended project kick-off event on June 14 for prospective buyers, renters and other partners.  Net Finance Expense was HK$35.8 million and Income Tax Expense was HK$47.2 million, which was partially offset by HK$17.0 million in Other Income, most of which was from Foreign Currency Gains.  Net Loss for the period was HK$27.4 million, or 1.98 cents per share, far below our estimate as we had assumed much faster sales of the Laurel House project.

N Land Contract Amendment.  On July 4, GDL amended its foundation pit support, earth and stone works, and piling works agreement with the contractor for its Northern Land site of GDH City, which will see GDL pay an additional HK$44.9 million.  The amendment was made primarily to account for the change in policy in Shenzhen requiring off-road vehicles to be new energy vehicles, which has markedly increased to cost to transport materials.  The change will ultimately result in a six month delay from the original timeline with this contractor, however management still believes the entirety of the N Land project will be completed as scheduled.

Related Party Sale - Laurel House Units.  On September 2, GDL announced it was selling a total of seven units from the Laurel House project to a subsidiary of its ultimate parent company, Guangdong Holdings.  A total of 692.65m2 was sold for cash at an average price of RMB 70,367 per m2, which falls in line with market prices.  GDL expects to report a net profit of RMB 2,642,000 from the sale of these units.  On July 18, GDL renewed its property management agreement with Yuehai Property Management for Laurel House, which now runs through 2020

Model Update.  Changes to our model include lengthening the time to contract and deliver units at Laurel House, increasing development expenses for GDH City as noted above, and making adjustments for the depreciation of the RMB relative to the HKD.

Maintaining Rating & Reducing Target.  The model changes noted above resulted in a reduction in our DCF valuation of the Company, from HK$4.75 to HK$4.25.  However, with GDH City making progress in terms of construction timeline and partner/tenant negotiations, we continue to believe GDL’s stock is undervalued at current prices.  As such we are reiterating our Buy rating on Guangdong Land.  Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.

Click Here>>


 

7-27-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Provides Update on Phase 2B Dose-Ranging, Efficacy Study for ATB-346

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain and inflammation, today provides an update on the Phase 2B dose-ranging, efficacy study for its lead drug, ATB-346. The clinical study commenced in March 2019 and is designed to validate the efficacy of ATB-346 in reducing pain and establish the dose for Phase 3 development. A total of 360 patients with osteoarthritis of the knee are being randomized to either placebo or one of three doses of ATB-346 administered once daily: 150 mg, 200 mg or 250 mg.

Read Complete Press Release

 

8-20-19 Canbiola, Inc. (OTCQB:CANB)
Canbiola Reports Second Quarter 2019 Results

Closed $3.9 Million Equity Raise Completed

HICKSVILLE, N.Y., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of variety of hemp-derived THC-Free Cannabidiol (CBD) Isolate products such as oils, drops/tinctures, creams, moisturizers, chews, and capsules, announced today the company's financial results for the second quarter ended June 30, 2019.

Key Financial Highlights for Q2 2019:

  • Revenues increased by 311% to $633,579
  • Gross margin of 52.8%
  • Operating loss of $1,435,289, included $959,948 in non-cash stock-based compensation
  • Closed $3,936,700 cash raised subsequent to the end of the quarter

Read Complete Press Release

 

8-7-19 Trickle Research issues update and allocation increase to 6
Camino Minerals Corp  OTC: CAMZF TSXV: COR.V
12-24 Month Price Target $0.90

We initiated coverage of Camino in 2Q18 with the idea that they owned and were developing a copper resource in Peru that we felt held some characteristics that might suggest it could become amajor project. We submit, we have not provided much in terms of updates to the story, because frankly, there is not a lot to update beyond drilling and exploration results. On the other hand, they have made some management changes, they have obtained some key permits to continue the development and they are working on the second portion of a raise to support the whole project. To revisit, the initiating coverage included a handful of bullet points that we thought supported our enthusiasm for the project. Here are some of the highlights from that initiation as well as some new comments around those bullet points (The initiation excerpts are in italics.)

Camino’s current focus is on a Peruvian project they refer to as Los Chapitos (“Chapitos”). Chapito’s location is relatively benign in terms of some of the conflicts resource deals often face. That is, it is located in an area with little other commercial or other appeal, which we think is favorable from permitting and other environmental impact sort of issues. On the other hand, the property is also only about 10 miles north of Chala, Peru, which is a coastal town of about 4,500 people. Further, the project is about 400 miles south of Lima, (Peru’s capital and largest city) and along the Pan American Highway, so it is not so remote that it is untenable in terms of access to relevant resources. Chapitos is easily accessible from Chala via a handful of gravel roads connected to the Pam American Highway.

Read Complete Report

 

8-2-19 Canbiola, Inc. (OTCQB:CANB)

Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine

Initial 25 Units Will Target Medical Offices

HICKSVILLE, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate announced today the launch of its own Canbiola-branded CBD product dispensing machine. An initial order for the first 25 units has been placed with the installations expected to occur in August and September.

Read Complete Press Release

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report

 

7-10-19 Endurance Exploration Group, Inc. (EXPL)
BWVI and EXPL Continue to Work Through 2019 Season

Jacksonville FL, July 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (BWVI) and project partner Endurance Exploration Group, Inc. (EXPL), are well into the 2019 recovery season on the SB Pulaski.   The SB Pulaski sank in 1838 while in route from Savannah, Georgia to Baltimore, Maryland.  She carried some of the South’s wealthiest families.  The shipwreck was considered the “Titanic” of its’ day.  

The Blue Water Rose has been based out of Wrightsville Beach, North Carolina since mid June.  As weather permits, on site excavations have continued with the recovery of more silver and copper coins; most from US origins, a small gold pocket watch, silver ware and wreck material.  A more detailed survey of bottom conditions has shown Hurricane Florence (September 2018) had a bigger impact on the seabed than was earlier believed.   The Blue Water dive team will continue with a methodical recovery plan to ensure that the entire wreck area will be thoroughly recorded and searched.  Keith Webb, President of Blue Water Ventures International, states, “We are very encouraged with the magnetometer results that were conducted in June and have now established the debris line which should unlock the Pulaski’s secrets.” 

Read Complete Press Release

 

Donald Capital, LLC, A New Investment Bank Opens Its Doors

NEW YORK, May 16, 2019 (GLOBE NEWSWIRE) – Donald Capital, LLC has launched today as a FINRA member Investment Bank. Founded with the intent to build a legacy based upon the fundamentals of honesty and integrity.

Donald Capital will focus on a market that has not been properly served for some time – the Private, Micro, Small & Mid Cap Markets. 

Co-founders Alex Hamilton and Don McDonald have launched several initiatives over their extensive careers to serve this part of the market.  They are very familiar with the challenges facing companies in this market and have the unique perspective to provide solutions.

Read Complete Press Release

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

September 11-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

08/19/19

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  07-10/19

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 

 


 

 

September 6th, 2019

ValuEngine Weekly Report

By: Paul Henneman

 

ValuEngine Market Valuation update for the week of September 6, 2019. Strong Buy stock pick for the week is ticker EXAS (Exact Sciences). As always ValuEngine data is updated daily on over 5,000 stocks and accounts for the recent activity in the markets. Read on for full updated numbers and stock pick.

Read more

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.
 

Categories Uncategorized, Weekly NewsletterTags market valuations, markets, sector, sector valuations, sectors, stock market, stock pick, STRONG BUY, STRONG BUY stocks, valuations, valuengine, ZNGA, Zynga

 

VALUATION WATCH: Overvalued stocks now make up 28.5% of our stocks assigned a valuation and 10.8% of those equities are calculated to be overvalued by 20% or more.

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

 

Black Swan Research Coverage and Subscription Service
Click Here>>

 

Event Calendar Updates

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.
Click Here for Details

 

The Rocky Mountain Microcap sponsored by GVC Capital and Dave Lavigne at Trickle Research LLC Conference will be held Nov 14-2019 at Coors Field in Denver.

Check back for details

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

This post has not been tagged.

Share |
PermalinkComments (0)
 

Stock Market Manager Weekly Update: September 4th, 2019

Posted By Administration, Thursday, September 5, 2019

SMM Logo

               

 

 

 

Weekly Update: September 4th, 2019

http://www.valuengine.com/images/newsletter/weekly/facebook-icon-743200.jpg

http://www.valuengine.com/images/newsletter/weekly/TWITTERICON.jpg

http://ecomallymail.com/uploads/1524105419.png

6,462

520

472

6

11

 

 

Black Swan Connection Newsletter Signup


Breaking News

We dodged another one- As you can see from what a CAT 5 Hurricane did to the sparsely populated Bahamian islands, if there were a direct hit of this magnitude on the mainland US the death toll and devastation would be on a scale that is hard to comprehend. The destruction wrought by Michael last year and Irma before was substantial. I can’t help but believe that the global warming increasing summer ocean temperatures even slightly have had a dramatic impact on the severity of Hurricanes.

 

CNN 9-4-19

Hurricane Dorian threatens the US after devastating the Bahamas

Apocalyptic scenes emerge from the Bahamas as the rush for aid begins

Freeport, Grand Bahama (CNN)What used to be stunning islands are now scenes of widespread destruction.

Hurricane Dorian pulverized the northern Bahamas for two days, hurling catastrophic winds and relentless rain. It was the strongest storm ever to make landfall in the island nation.

"Nothing compares to what we went through the past two days," survivor Michael Hynes said. "Almost 48 hours now with nonstop carnage."

Read Complete Article


 

7-27-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Provides Update on Phase 2B Dose-Ranging, Efficacy Study for ATB-346

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain and inflammation, today provides an update on the Phase 2B dose-ranging, efficacy study for its lead drug, ATB-346. The clinical study commenced in March 2019 and is designed to validate the efficacy of ATB-346 in reducing pain and establish the dose for Phase 3 development. A total of 360 patients with osteoarthritis of the knee are being randomized to either placebo or one of three doses of ATB-346 administered once daily: 150 mg, 200 mg or 250 mg.

Read Complete Press Release

 

8-20-19 Canbiola, Inc. (OTCQB:CANB)
Canbiola Reports Second Quarter 2019 Results

Closed $3.9 Million Equity Raise Completed

HICKSVILLE, N.Y., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of variety of hemp-derived THC-Free Cannabidiol (CBD) Isolate products such as oils, drops/tinctures, creams, moisturizers, chews, and capsules, announced today the company's financial results for the second quarter ended June 30, 2019.

Key Financial Highlights for Q2 2019:

  • Revenues increased by 311% to $633,579
  • Gross margin of 52.8%
  • Operating loss of $1,435,289, included $959,948 in non-cash stock-based compensation
  • Closed $3,936,700 cash raised subsequent to the end of the quarter

Read Complete Press Release

 

8-7-19 Trickle Research issues update and allocation increase to 6
Camino Minerals Corp  OTC: CAMZF TSXV: COR.V
12-24 Month Price Target $0.90

We initiated coverage of Camino in 2Q18 with the idea that they owned and were developing a copper resource in Peru that we felt held some characteristics that might suggest it could become amajor project. We submit, we have not provided much in terms of updates to the story, because frankly, there is not a lot to update beyond drilling and exploration results. On the other hand, they have made some management changes, they have obtained some key permits to continue the development and they are working on the second portion of a raise to support the whole project. To revisit, the initiating coverage included a handful of bullet points that we thought supported our enthusiasm for the project. Here are some of the highlights from that initiation as well as some new comments around those bullet points (The initiation excerpts are in italics.)

Camino’s current focus is on a Peruvian project they refer to as Los Chapitos (“Chapitos”). Chapito’s location is relatively benign in terms of some of the conflicts resource deals often face. That is, it is located in an area with little other commercial or other appeal, which we think is favorable from permitting and other environmental impact sort of issues. On the other hand, the property is also only about 10 miles north of Chala, Peru, which is a coastal town of about 4,500 people. Further, the project is about 400 miles south of Lima, (Peru’s capital and largest city) and along the Pan American Highway, so it is not so remote that it is untenable in terms of access to relevant resources. Chapitos is easily accessible from Chala via a handful of gravel roads connected to the Pam American Highway.

Read Complete Report

 

8-2-19 Canbiola, Inc. (OTCQB:CANB)

Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine

Initial 25 Units Will Target Medical Offices

HICKSVILLE, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate announced today the launch of its own Canbiola-branded CBD product dispensing machine. An initial order for the first 25 units has been placed with the installations expected to occur in August and September.

Read Complete Press Release

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report

 

7-10-19 Endurance Exploration Group, Inc. (EXPL)
BWVI and EXPL Continue to Work Through 2019 Season

Jacksonville FL, July 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (BWVI) and project partner Endurance Exploration Group, Inc. (EXPL), are well into the 2019 recovery season on the SB Pulaski.   The SB Pulaski sank in 1838 while in route from Savannah, Georgia to Baltimore, Maryland.  She carried some of the South’s wealthiest families.  The shipwreck was considered the “Titanic” of its’ day.  

The Blue Water Rose has been based out of Wrightsville Beach, North Carolina since mid June.  As weather permits, on site excavations have continued with the recovery of more silver and copper coins; most from US origins, a small gold pocket watch, silver ware and wreck material.  A more detailed survey of bottom conditions has shown Hurricane Florence (September 2018) had a bigger impact on the seabed than was earlier believed.   The Blue Water dive team will continue with a methodical recovery plan to ensure that the entire wreck area will be thoroughly recorded and searched.  Keith Webb, President of Blue Water Ventures International, states, “We are very encouraged with the magnetometer results that were conducted in June and have now established the debris line which should unlock the Pulaski’s secrets.” 

Read Complete Press Release

 

Donald Capital, LLC, A New Investment Bank Opens Its Doors

NEW YORK, May 16, 2019 (GLOBE NEWSWIRE) – Donald Capital, LLC has launched today as a FINRA member Investment Bank. Founded with the intent to build a legacy based upon the fundamentals of honesty and integrity.

Donald Capital will focus on a market that has not been properly served for some time – the Private, Micro, Small & Mid Cap Markets. 

Co-founders Alex Hamilton and Don McDonald have launched several initiatives over their extensive careers to serve this part of the market.  They are very familiar with the challenges facing companies in this market and have the unique perspective to provide solutions.

Read Complete Press Release

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

September 3-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

08/19/19

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  07-10/19

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 

 

 


 

 

September 1st, 2019

ValuEngine Weekly Report

By: Paul Henneman

ValuEngine Market Valuation update for the week of August 30, 2019. Strong Buy stock pick for the week is ticker SHOP (Shopify Inc). As always ValuEngine data is updated daily and accounts for the recent activity in the markets. Read on for full updated numbers and stock pick. Read more

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.
 

Categories Uncategorized, Weekly NewsletterTags market valuations, markets, sector, sector valuations, sectors, stock market, stock pick, STRONG BUY, STRONG BUY stocks, valuations, valuengine, ZNGA, Zynga

VALUATION WATCH: Overvalued stocks now make up 28.09% of our stocks assigned a valuation and 10.94% of those equities are calculated to be overvalued by 20% or more.

 

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

 

Black Swan Research Coverage and Subscription Service
Click Here>>

 

Event Calendar Updates

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.
Click Here for Details

 

The Rocky Mountain Microcap sponsored by GVC Capital and Dave Lavigne at Trickle Research LLC Conference will be held Nov 14-2019 at Coors Field in Denver.

Check back for details

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

This post has not been tagged.

Share |
PermalinkComments (0)
 

Stock Market Manager Weekly Update: August 27th, 2019

Posted By Administration, Thursday, August 29, 2019

SMM Logo

               

 

 

 

Weekly Update: August 27th, 2019

http://www.valuengine.com/images/newsletter/weekly/facebook-icon-743200.jpg

http://www.valuengine.com/images/newsletter/weekly/TWITTERICON.jpg

http://ecomallymail.com/uploads/1524105419.png

6,462

520

472

6

11

 

 

Black Swan Connection Newsletter Signup


Breaking News

 

Barrons  Aug-27-19
 

Boeing has been one of the great American Industrial success stories ever. Helped win wars and a leader in aviation and defense technology. My bet these bad news hiccups are a buying opportunity.

Boeing Stock Shrugs Off 737 MAX Order Loss

Boeing shares are down about 15% since mid-March, far worse than the Dow or other aerospace suppliers, after the tragic crash of an Ethiopian Airlines 737 MAX jet, the second crash involving a MAX over a few months. Worldwide aviation authorities grounded the plane, while Boeing works to update flight control software implicated in both accidents. What's new: Avia Capital Services, a subsidiary of state-owned Russian conglomerate Rostec, is suing Boeing to cancel 737 MAX orders.

Read Complete Article

 


7-27-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Provides Update on Phase 2B Dose-Ranging, Efficacy Study for ATB-346

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain and inflammation, today provides an update on the Phase 2B dose-ranging, efficacy study for its lead drug, ATB-346. The clinical study commenced in March 2019 and is designed to validate the efficacy of ATB-346 in reducing pain and establish the dose for Phase 3 development. A total of 360 patients with osteoarthritis of the knee are being randomized to either placebo or one of three doses of ATB-346 administered once daily: 150 mg, 200 mg or 250 mg.

Read Complete Press Release

 

8-20-19 Canbiola, Inc. (OTCQB:CANB)
Canbiola Reports Second Quarter 2019 Results

Closed $3.9 Million Equity Raise Completed

HICKSVILLE, N.Y., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of variety of hemp-derived THC-Free Cannabidiol (CBD) Isolate products such as oils, drops/tinctures, creams, moisturizers, chews, and capsules, announced today the company's financial results for the second quarter ended June 30, 2019.

Key Financial Highlights for Q2 2019:

  • Revenues increased by 311% to $633,579
  • Gross margin of 52.8%
  • Operating loss of $1,435,289, included $959,948 in non-cash stock-based compensation
  • Closed $3,936,700 cash raised subsequent to the end of the quarter

Read Complete Press Release

 

8-7-19 Trickle Research issues update and allocation increase to 6
Camino Minerals Corp  OTC: CAMZF TSXV: COR.V
12-24 Month Price Target $0.90

We initiated coverage of Camino in 2Q18 with the idea that they owned and were developing a copper resource in Peru that we felt held some characteristics that might suggest it could become amajor project. We submit, we have not provided much in terms of updates to the story, because frankly, there is not a lot to update beyond drilling and exploration results. On the other hand, they have made some management changes, they have obtained some key permits to continue the development and they are working on the second portion of a raise to support the whole project. To revisit, the initiating coverage included a handful of bullet points that we thought supported our enthusiasm for the project. Here are some of the highlights from that initiation as well as some new comments around those bullet points (The initiation excerpts are in italics.)

Camino’s current focus is on a Peruvian project they refer to as Los Chapitos (“Chapitos”). Chapito’s location is relatively benign in terms of some of the conflicts resource deals often face. That is, it is located in an area with little other commercial or other appeal, which we think is favorable from permitting and other environmental impact sort of issues. On the other hand, the property is also only about 10 miles north of Chala, Peru, which is a coastal town of about 4,500 people. Further, the project is about 400 miles south of Lima, (Peru’s capital and largest city) and along the Pan American Highway, so it is not so remote that it is untenable in terms of access to relevant resources. Chapitos is easily accessible from Chala via a handful of gravel roads connected to the Pam American Highway.

Read Complete Report

 

8-2-19 Canbiola, Inc. (OTCQB:CANB)

Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine

Initial 25 Units Will Target Medical Offices

HICKSVILLE, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate announced today the launch of its own Canbiola-branded CBD product dispensing machine. An initial order for the first 25 units has been placed with the installations expected to occur in August and September.

Read Complete Press Release

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report

 

7-10-19 Endurance Exploration Group, Inc. (EXPL)
BWVI and EXPL Continue to Work Through 2019 Season

Jacksonville FL, July 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (BWVI) and project partner Endurance Exploration Group, Inc. (EXPL), are well into the 2019 recovery season on the SB Pulaski.   The SB Pulaski sank in 1838 while in route from Savannah, Georgia to Baltimore, Maryland.  She carried some of the South’s wealthiest families.  The shipwreck was considered the “Titanic” of its’ day.  

The Blue Water Rose has been based out of Wrightsville Beach, North Carolina since mid June.  As weather permits, on site excavations have continued with the recovery of more silver and copper coins; most from US origins, a small gold pocket watch, silver ware and wreck material.  A more detailed survey of bottom conditions has shown Hurricane Florence (September 2018) had a bigger impact on the seabed than was earlier believed.   The Blue Water dive team will continue with a methodical recovery plan to ensure that the entire wreck area will be thoroughly recorded and searched.  Keith Webb, President of Blue Water Ventures International, states, “We are very encouraged with the magnetometer results that were conducted in June and have now established the debris line which should unlock the Pulaski’s secrets.” 

Read Complete Press Release

 

Donald Capital, LLC, A New Investment Bank Opens Its Doors

NEW YORK, May 16, 2019 (GLOBE NEWSWIRE) – Donald Capital, LLC has launched today as a FINRA member Investment Bank. Founded with the intent to build a legacy based upon the fundamentals of honesty and integrity.

Donald Capital will focus on a market that has not been properly served for some time – the Private, Micro, Small & Mid Cap Markets. 

Co-founders Alex Hamilton and Don McDonald have launched several initiatives over their extensive careers to serve this part of the market.  They are very familiar with the challenges facing companies in this market and have the unique perspective to provide solutions.

Read Complete Press Release

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

August 27-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

08/19/19

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  07-10/19

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 

 

 

August 23rd, 2019

ValuEngine Weekly Report

By: Paul Henneman

 

ValuEngine Market Valuation update for the week of August 23, 2019. Strong Buy stock pick for the week is ticker RNG (Ringcentral, Inc). Nearly 72% of the 4000 stocks covered by ValuEngine are now undervalued as the market pulls back. Read on for full updated numbers and stock pick. Read more

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.
 

Categories Uncategorized, Weekly NewsletterTags market valuations, markets, sector, sector valuations, sectors, stock market, stock pick, STRONG BUY, STRONG BUY stocks, valuations, valuengine, ZNGA, Zynga

 

VALUATION WATCH: Overvalued stocks now make up 28.09% of our stocks assigned a valuation and 10.94% of those equities are calculated to be overvalued by 20% or more.

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

 

Black Swan Research Coverage and Subscription Service
Click Here>>

 

Event Calendar Updates

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.
Click Here for Details

 

The Rocky Mountain Microcap sponsored by GVC Capital and Dave Lavigne at Trickle Research LLC Conference will be held Nov 14-2019 at Coors Field in Denver.

Check back for details

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

 

This post has not been tagged.

Share |
PermalinkComments (0)
 

Stock Market Manager Weekly Update: August 21st, 2019

Posted By Administration, Thursday, August 22, 2019

SMM Logo

               

 

 

 

Weekly Update: August 21st, 2019

http://www.valuengine.com/images/newsletter/weekly/facebook-icon-743200.jpg

http://www.valuengine.com/images/newsletter/weekly/TWITTERICON.jpg

http://ecomallymail.com/uploads/1524105419.png

6,462

520

472

6

11

 

 

Black Swan Connection Newsletter Signup


Breaking News

FX Empire  Aug-19-19

S&P 500 Price Forecast – Stock markets head towards massive resistance

The S&P 500 rallied a bit during the trading session on Monday, slamming into the 50 day EMA by the time traders started to settle into their desks. The question now is whether or not we can continue from here, because the 50 day EMA has attracted a lot of selling pressure over the last several sessions, just as the 200 day EMA continues to attract a lot of buying pressure. I think at this point though, we need to see is a break above the 2950 level to feel a little bit more confident about going long of this market.

Read Complete Article


Great Article on Picking Junior Mining Companies-

Mike Sheikh -Falcon Strategic Research
8-20-19

Gold Sector Snapshot – Criteria for Picking Junior Miners

  • Gold prices appreciated 18% YTD
  • Uncertainty in the world economy driving prices
  • Rising prices helping increase feasibility of shut in mines
  • Criteria to picking the ideal Junior Miner

Gold prices are on an upswing and investors looking to park some money in the sector should be aware of some of the nuances of gold investing.  Gold has appreciated 18% in part due to the China trade war dialog and the political uncertainty around the world.  In addition, increases in volatility cause people to desire gold more.  The Junior miners have moved in pretty much lock step with gold prices but there seems to be small divergence that investors might want to capitalize in buying assets at a discount.    This article is going to explore some of the methods used to evaluate Junior Miners.  

Read Complete Report

 

8-20-19 Canbiola, Inc. (OTCQB:CANB)
Canbiola Reports Second Quarter 2019 Results

Closed $3.9 Million Equity Raise Completed

HICKSVILLE, N.Y., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of variety of hemp-derived THC-Free Cannabidiol (CBD) Isolate products such as oils, drops/tinctures, creams, moisturizers, chews, and capsules, announced today the company's financial results for the second quarter ended June 30, 2019.

Key Financial Highlights for Q2 2019:

  • Revenues increased by 311% to $633,579
  • Gross margin of 52.8%
  • Operating loss of $1,435,289, included $959,948 in non-cash stock-based compensation
  • Closed $3,936,700 cash raised subsequent to the end of the quarter

Read Complete Press Release

 

8-7-19 Trickle Research issues update and allocation increase to 6
Camino Minerals Corp  OTC: CAMZF TSXV: COR.V
12-24 Month Price Target $0.90

We initiated coverage of Camino in 2Q18 with the idea that they owned and were developing a copper resource in Peru that we felt held some characteristics that might suggest it could become amajor project. We submit, we have not provided much in terms of updates to the story, because frankly, there is not a lot to update beyond drilling and exploration results. On the other hand, they have made some management changes, they have obtained some key permits to continue the development and they are working on the second portion of a raise to support the whole project. To revisit, the initiating coverage included a handful of bullet points that we thought supported our enthusiasm for the project. Here are some of the highlights from that initiation as well as some new comments around those bullet points (The initiation excerpts are in italics.)

Camino’s current focus is on a Peruvian project they refer to as Los Chapitos (“Chapitos”). Chapito’s location is relatively benign in terms of some of the conflicts resource deals often face. That is, it is located in an area with little other commercial or other appeal, which we think is favorable from permitting and other environmental impact sort of issues. On the other hand, the property is also only about 10 miles north of Chala, Peru, which is a coastal town of about 4,500 people. Further, the project is about 400 miles south of Lima, (Peru’s capital and largest city) and along the Pan American Highway, so it is not so remote that it is untenable in terms of access to relevant resources. Chapitos is easily accessible from Chala via a handful of gravel roads connected to the Pam American Highway.

Read Complete Report

 

8-2-19 Canbiola, Inc. (OTCQB:CANB)

Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine

Initial 25 Units Will Target Medical Offices

HICKSVILLE, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate announced today the launch of its own Canbiola-branded CBD product dispensing machine. An initial order for the first 25 units has been placed with the installations expected to occur in August and September.

Read Complete Press Release

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report

 

7-10-19 Endurance Exploration Group, Inc. (EXPL)
BWVI and EXPL Continue to Work Through 2019 Season

Jacksonville FL, July 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (BWVI) and project partner Endurance Exploration Group, Inc. (EXPL), are well into the 2019 recovery season on the SB Pulaski.   The SB Pulaski sank in 1838 while in route from Savannah, Georgia to Baltimore, Maryland.  She carried some of the South’s wealthiest families.  The shipwreck was considered the “Titanic” of its’ day.  

The Blue Water Rose has been based out of Wrightsville Beach, North Carolina since mid June.  As weather permits, on site excavations have continued with the recovery of more silver and copper coins; most from US origins, a small gold pocket watch, silver ware and wreck material.  A more detailed survey of bottom conditions has shown Hurricane Florence (September 2018) had a bigger impact on the seabed than was earlier believed.   The Blue Water dive team will continue with a methodical recovery plan to ensure that the entire wreck area will be thoroughly recorded and searched.  Keith Webb, President of Blue Water Ventures International, states, “We are very encouraged with the magnetometer results that were conducted in June and have now established the debris line which should unlock the Pulaski’s secrets.” 

Read Complete Press Release

 

Donald Capital, LLC, A New Investment Bank Opens Its Doors

NEW YORK, May 16, 2019 (GLOBE NEWSWIRE) – Donald Capital, LLC has launched today as a FINRA member Investment Bank. Founded with the intent to build a legacy based upon the fundamentals of honesty and integrity.

Donald Capital will focus on a market that has not been properly served for some time – the Private, Micro, Small & Mid Cap Markets. 

Co-founders Alex Hamilton and Don McDonald have launched several initiatives over their extensive careers to serve this part of the market.  They are very familiar with the challenges facing companies in this market and have the unique perspective to provide solutions.

Read Complete Press Release

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

 

August 6-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

08/19/19

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  07-10/19

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 

 

 

 

 

August 19th, 2019

ValuEngine Weekly Report

By: Paul Henneman

ValuEngine Market Valuation update for the week of August 16, 2019. Strong Buy stock pick for the week is ticker SGEN (Seattle Genetic). All Sector groups are now undervalued on average by the models, after the tough market last week. Read on for full updated numbers and stock pick. www.ValuEngine.com to log in, or free two-week …Read more

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.
 

Categories Uncategorized, Weekly NewsletterTags market valuations, markets, sector, sector valuations, sectors, stock market, stock pick, STRONG BUY, STRONG BUY stocks, valuations, valuengine, ZNGA, Zynga

 

VALUATION WATCH: Overvalued stocks now make up 23.12% of our stocks assigned a valuation and 9.21% of those equities are calculated to be overvalued by 20% or more.

 

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

 

Black Swan Research Coverage and Subscription Service
Click Here>>

 

Event Calendar Updates

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.
Click Here for Details

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

This post has not been tagged.

Share |
PermalinkComments (0)
 

Black Swan Connection August 2019

Posted By Administration, Monday, August 19, 2019

August 2019

                

 6,462     1,414       472         8           6


Our goal with the Black Swan Connection is to provide our subscribers, investors and financial professional compatriots outstanding investment insight that is a step above and outside of what will normally be found in mainstream financial press. To that end we have brought together seasoned, successful, and some of the brightest professionals in their respective fields to provide the articles and advice that is based on decades of practice in the field.

Black Swan Connection Newsletter Signup

 

Breaking News

 

Tesla is a story we’ve been covering for a while- No good news here…..

Slumping Tesla Stock Headed Into Test of 2019 Low

Controversial automaker Tesla, Inc. (TSLA) is slumping badly in this tough summer market, dropping like a rock after a six-week oversold rally reversed in July at major resistance between $250 and $270. Adding to growing shareholder anxiety, the stock just broke intermediate support near $230, exposing a second trip into the psychological $200 level and a critical test at June's three-year low at $176.99. First, Wall Street is concerned Tesla doesn't have a viable path to profitability after it reported a much greater-than-expected loss in July's quarterly report.

Read Full Commentary

 

Feature Article

For Microcaps…Its Rough Out There

By: Dave Lavigne

August 2019

I have been providing independent microcap stock research under my own labels since 2002.  Prior to that, I provided the same on the sell side for small regional broker dealers, and that included research as a part of those entities’ corporate finance due diligence. I have been at this a while.

Over those periods that I was preparing research for “public consumption” I kept a track record of  sorts comparing my research universe to that of the performances of three major U.S. equity indices; the Dow Jones Industrial Average, the NASDAQ and the S&P 500. Over much of that period, (and over reasonable periods of time) my research universes typically outperformed those indices, and often by meaningful margins.  As a matter of full disclosure, there are a number of nuances that impact the relevance of those comparisons (transaction costs, spreads, liquidity etc.), so I fully submit, while the stock picks as whole have performed well, I am certainly no guru, and comparing the picks to those indices has some holes. 

Read Complete Article
 

8-2-19 Canbiola, Inc. (OTCQB:CANB)

Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine

Initial 25 Units Will Target Medical Offices

HICKSVILLE, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate announced today the launch of its own Canbiola-branded CBD product dispensing machine. An initial order for the first 25 units has been placed with the installations expected to occur in August and September.

Read Complete Press Release

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

 

SMM Coverage-Special Situations

Elio Motors, Inc. (ELIO) $.93 8-15-19

What’s that old song? - slip sliding away……

Petition for class action lawsuit

SHORT- Elio Motors, Inc. –ELIO Nov-2016  $11.80  Dec 17-18 price $3.15 starting to slip slide away again. (nice chance to add to short if you can get a borrow on ELIO).  Last news was almost 5 months ago from company. Still on perpetual begathon for new reservations. Still needs $300 million plus another $545,000 to cover this fine, but reality is that this car cannot be built for the price he talks about.


Nothing new in SEC Filings and no news now for 7 months- That’s NOT good news

Posted by u/snugglesdog

 

 

August-19 MODEL PORTFOLIO FOR TRICKLE RESEARCH, LLC.:

 

Initiation

 

Price

Initiation

Price @

 

Stock

Symbol

Date

Allocation

Target

Cost Px.

8/8/2019

 

SRAX (Social Reality)

SRAX

Multiple

5

$15.00

$1.79

$3.76

 

Pure Cycle

PCYO

5/5/17

3

$12.00

$7.60

$10.74

 

Command Center

CCNI

9/8/17

5

$8.75

$4.44

$7.75

 

Endurance Exploration

EXPL

11/6/17

3

$0.29

$0.18

$0.12

 

Assure Holdings Corp.

ARHH

11/10/17

5

$6.00

$2.90

$1.44

 

AzurRx BioPharma

AZRZ

2/7/18

7

$10.25

$2.96

$0.94

 

Camino Minerals, Corp

CAMZF

4/6/18

6

$0.90

$0.26

$0.09

 

PetroShare Corp

PRHR

5/31/18

5

$2.65

$1.44

$0.06

 

Gold Resource Corp

GORO

7/30/18

5

$7.35

$6.49

$3.60

 

Summit Wirelss

WISA

9/28/18

5

$9.25

$4.30

$0.99

 

Alvoperto Energy, Ltd.

ALVOF

11/7/18

5

$1.10

$0.39

$0.57

 

SG Blocks

SGBX

2/28/19

5

$6.25

$2.84

$6.25

 

H-Source Holdings

HSCHF

4/9/19

4

$0.19

$.06

$0.04

 

Generation Next Brands

VEND

4/10/19

3

$1.10

$.59

$.050

 

 

 

Initiation

 Termination 

 

Price

Initiation

Termination

Terminated Coverage

Symbol

Date

Date

Allocation

Target

Price

Price

ID Watchdog

IDW

10/13/16

8/28/2017

4

$0.42

$0.14

$0.40

GrowGeneration

GRWG

6/20/17

12/21/17

4

$3.40

$2.00

       $3.44  

Barfresh Food Group

BRFH

 

8/20/18

1

 

$0.55

$0.53

Semler Scientific

SMLR

12/27/17

11/7/18

    4

$15.00

$8.00

$31.99

New Jersey Mining

NJMC

4-18

5/16/19

           3

$0.30

$0.12

$1.31

 

 

 

 

 

 

 

 

 

For complete details and assumptions please see the assumptions and explanations document Click Here

For a review and details on 2017 performance and model portfolio assumptions  Click Here

*Please note Dave Lavigne in the principal in Trickle Research and is also the editor of the Black Swan Connection Newsletter and an ongoing contributor to SMM.

 

August 15-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

04/06/18

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  03-26/19

News

FULLSHARE HOLDINGS LTD. (607) HK

 

09/07/18

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 

 

Go to ValuEngine.com

    
 

August 9th, 2019  by Paul Henneman

ValuEngine Market Valuation update for the week of August 9, 2019. Stock pick of the week is ticker ALNY (Alnylam Pharmaceuticals, Inc.). The models continue to like the markets better than previously in 2019 after the recent pull back with nearly 70% of stocks covered now undervalued. Read on for full updated numbers and stock pick.

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.

 

VALUATION WATCH: Overvalued stocks now make up 30.78% of our stocks assigned a

valuation and 11.72% of those equities are calculated to be overvalued by 20% or more.

Read Full Report

 

SMM Research Subscription Service.
Black Swan Research

Subscribers will get Real Time notification as Research Reports and updates are available as well as latest press releases and news on the companies covered.

Black Swan Research coverage is a compilation of some of the best independent providers of Micro Cap Research.  The service focuses on micro-cap companies that are typically not followed by Wall Street analysts.  In addition our subscription research service includes ValuEngine research on over 5,000 stocks with stock valuations, Buy/Hold/Sell recommendations, and forecasted target prices.

 Click Here for Complete Description

See Below for current coverage and info regarding our Research providers

Trickle Research Click Here for More info>>

*Research on the following companies is available to BS Research or Trickle research subscribers only

  • Pure Cycle (PCYO)  -

  • Semler Scientific, Inc. (SMLR)

Greenridge Global, LLC Click Here for More Info>>

ValuEngine Click Here for More Info >>

ValuEngine.com (VE) is a stock valuation and forecasting service founded by Ivy League finance academics. VE utilizes the most advanced quantitative techniques and analysis available.

To Subscribe Please click Here
 

Reg A or D 506(c)

If you have a Reg A or 506(c) offering you would like us to distribute to our database, please give us a ring or email to:
727-823-3987
cdilley@smm.global

 


Event Calendar Updates

Summer doldrums- Nothing coming up immediately

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.

Click Here for Details


Carl Dilley
cdilley@smm.global

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)       1,414

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                                0

Direct Email     *                                                          249,000

Total                                                                           257,354

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

 

This post has not been tagged.

Share |
PermalinkComments (0)
 

Stock Market Manager Weekly Update: August 6th, 2019

Posted By Administration, Thursday, August 8, 2019

SMM Logo

               

 

 

 

Weekly Update: August 6th, 2019

 

http://www.valuengine.com/images/newsletter/weekly/facebook-icon-743200.jpg

http://www.valuengine.com/images/newsletter/weekly/TWITTERICON.jpg

http://ecomallymail.com/uploads/1524105419.png

6,462

520

472

6

11

 

 

Black Swan Connection Newsletter Signup


Breaking News

Yahoo Finance Aug-6-19
Why investors should get used to market volatility

The ongoing U.S.-China trade war has evolved into a currency war with markets moving off their worst day of the year. Yahoo Finance's Julie Hyman, Adam Shapiro, Sibile Marcellus, David Kotok of Cumberland Advisors and Ron Weiner - RDM Financial Group at HighTower Managing Director and Partner discuss.

Read Complete Article

 

8-2-19 Canbiola, Inc. (OTCQB:CANB)

Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine

Initial 25 Units Will Target Medical Offices

HICKSVILLE, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate announced today the launch of its own Canbiola-branded CBD product dispensing machine. An initial order for the first 25 units has been placed with the installations expected to occur in August and September.

Read Complete Press Release

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report

 

7-10-19 Endurance Exploration Group, Inc. (EXPL)
BWVI and EXPL Continue to Work Through 2019 Season

Jacksonville FL, July 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (BWVI) and project partner Endurance Exploration Group, Inc. (EXPL), are well into the 2019 recovery season on the SB Pulaski.   The SB Pulaski sank in 1838 while in route from Savannah, Georgia to Baltimore, Maryland.  She carried some of the South’s wealthiest families.  The shipwreck was considered the “Titanic” of its’ day.  

The Blue Water Rose has been based out of Wrightsville Beach, North Carolina since mid June.  As weather permits, on site excavations have continued with the recovery of more silver and copper coins; most from US origins, a small gold pocket watch, silver ware and wreck material.  A more detailed survey of bottom conditions has shown Hurricane Florence (September 2018) had a bigger impact on the seabed than was earlier believed.   The Blue Water dive team will continue with a methodical recovery plan to ensure that the entire wreck area will be thoroughly recorded and searched.  Keith Webb, President of Blue Water Ventures International, states, “We are very encouraged with the magnetometer results that were conducted in June and have now established the debris line which should unlock the Pulaski’s secrets.” 

Read Complete Press Release

 

Donald Capital, LLC, A New Investment Bank Opens Its Doors

NEW YORK, May 16, 2019 (GLOBE NEWSWIRE) – Donald Capital, LLC has launched today as a FINRA member Investment Bank. Founded with the intent to build a legacy based upon the fundamentals of honesty and integrity.

Donald Capital will focus on a market that has not been properly served for some time – the Private, Micro, Small & Mid Cap Markets. 

Co-founders Alex Hamilton and Don McDonald have launched several initiatives over their extensive careers to serve this part of the market.  They are very familiar with the challenges facing companies in this market and have the unique perspective to provide solutions.

Read Complete Press Release

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

 

August 6-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

04/06/18

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  07-10/19

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19          

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 
 

 

 

August 2nd, 2019

ValuEngine Weekly Report

By: Paul Henneman

ValuEngine Market Valuation update for the week of August 2, 2019. Stock pick of the week is ticker FICO (Fair Issac Inc). The VE Valuation models improved somewhat after this week’s pull back. All but two sectors and 65% of individual stocks covered now undervalued. Read on for full updated numbers. www.ValuEngine.com to log in, or … Read more

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.
 

Categories Uncategorized, Weekly NewsletterTags market valuations, markets, sector, sector valuations, sectors, stock market, stock pick, STRONG BUY, STRONG BUY stocks, valuations, valuengine, ZNGA, Zynga

VALUATION WATCH: Overvalued stocks now make up 34.30% of our stocks assigned a valuation and 12.45% of those equities are calculated to be overvalued by 20% or more.

 

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

 

Black Swan Research Coverage and Subscription Service
Click Here>>

 

Event Calendar Updates

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.
Click Here for Details

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

This post has not been tagged.

Share |
PermalinkComments (0)
 

Stock Market Manager Weekly Update: July 31st, 2019

Posted By Administration, Friday, August 2, 2019

SMM Logo

               

 

 

 

Weekly Update: July 31st, 2019

http://www.valuengine.com/images/newsletter/weekly/facebook-icon-743200.jpg

http://www.valuengine.com/images/newsletter/weekly/TWITTERICON.jpg

http://ecomallymail.com/uploads/1524105419.png

6,462

520

472

6

11

 

 

Black Swan Connection Newsletter Signup


Breaking News

Yahoo Finance Aug-2-19
 

July job report, Fed rate cut as Trump raises tariffs

In the past week, the Federal Reserve cut rates by a quarter point, President Trump announced that he will impose a 10% tariff on $300 billion on Chinese good, in addition to the July Jobs report. Yahoo Finance's Scott Gamm shares how the markets are reacting.  Read Complete Article

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.  
Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)

  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.

  • First patient visits have been completed in Hungary.

  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.  Read Complete Report

 

7-10-19 Endurance Exploration Group, Inc. (EXPL)
BWVI and EXPL Continue to Work Through 2019 Season

Jacksonville FL, July 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (BWVI) and project partner Endurance Exploration Group, Inc. (EXPL), are well into the 2019 recovery season on the SB Pulaski.   The SB Pulaski sank in 1838 while in route from Savannah, Georgia to Baltimore, Maryland.  She carried some of the South’s wealthiest families.  The shipwreck was considered the “Titanic” of its’ day.  

The Blue Water Rose has been based out of Wrightsville Beach, North Carolina since mid June.  As weather permits, on site excavations have continued with the recovery of more silver and copper coins; most from US origins, a small gold pocket watch, silver ware and wreck material.  A more detailed survey of bottom conditions has shown Hurricane Florence (September 2018) had a bigger impact on the seabed than was earlier believed.   The Blue Water dive team will continue with a methodical recovery plan to ensure that the entire wreck area will be thoroughly recorded and searched.  Keith Webb, President of Blue Water Ventures International, states, “We are very encouraged with the magnetometer results that were conducted in June and have now established the debris line which should unlock the Pulaski’s secrets.”   Read Complete Press Release

 

6-12-19 Canbiola, Inc. (CANB)
Canbiola Presentation from Annual Shareholder Meeting is Publicly Available

HICKSVILLE, NY, July 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola,Inc. (OTCQB: CANB)(“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that its presentation from its Annual Shareholder Meeting held on Friday, June 14, is now publicly available.

We encourage you to read the filing at:

https://www.sec.gov/Archives/edgar/data/1509957/000149315219009362/0001493152-19-009362-index.htm

Canbiola Chief Executive Officer Marco Alfonsi commented, “We want to thank all of our shareholders, especially the 100+ that attended our meeting a couple of weeks ago. Our entire team was thrilled with the turn out and enthusiasm.  Read Complete Press Release

 

6-12-19 Canbiola, Inc. (CANB)
Canbiola and Shi Farms Execute Letter of Intent to Form Joint Venture for Hemp Cultivation & Processing

Plans to Open a NY Depot for Hemp Cultivation

HICKSVILLE, NY, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that has entered into a non-binding Letter of Intent (the “LOI”) with Shi Farms, Inc. (“Shi Farms”), a licensed Hemp Cultivation Operation under the Colorado Department of Agriculture, operating a 300-acre farm and 40,000 square feet of research greenhouses to grow, cultivate, accumulate and process hemp in New York State under a license from Shi Farms. 

For more information about Shi Farms, please visit: https://www.shifarms.com.

Read Complete Press Release

 

 6-6-2019 Greenridge Global Equity Research Issues Update Guangdong Land Holdings, Ltd. HKSE 0124
Maintaining rating and Buy target HK$ 4.75

Hou Wailin Joins GDL As Chairman Of The Board

Hou Wailin Joins GDL as Chairman of the Board.  Effective yesterday, June 5, Chairman Huang Xiaofeng tendered his resignation as Non-Executive Director and Chairman of the Board after reaching his retirement age.  Chairman Huang served in these positions for roughly ten years and oversaw the transition from Kingway Brewery to a real estate development firm.  Concurrent with this announcement, Mr. Hou Wailin was appointed Non-Executive Director and Chairman of the Board.  Mr. Hou was appointed Chairman of Guangdong Holdings and GDH Limited, the ultimate parent companies of GDL, in May 2019.  Previous experience includes serving as Chairman of Guangdong Technology Financial Group and as Director-General of Guangdong Regulatory Bureau of the China Securities Regulatory Commission (“CSRC”) and Chief Inspector of the General Inspection Taskforce of CSRC.  Similar to Chairman Huang, Chairman Hou will not receive any compensation for this position.  We do not expect any significant shifts in the direction of GDL with this change.

AGM Today.  The AGM will be held later today (June 6, 2019) at 3pm in the Concord Room of the Renaissance Hotel in Wan Chai.

Model Update.  We have made no changes to our model as we expect a continuation of the current business model.

Maintaining Rating & Target.  With no changes to our model we are reiterating our Buy rating and HK$4.75 target price on Guangdong Land.  We continue to believe the current share price does not accurately reflect the underlying value of the Company’s real estate portfolio or the GDH City project.  Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.  Read Complete Report

 

6-4-19 Trickle Research Issues Allocation Update Report
Summit Wireless Technologies, Inc.  Nasdaq (WISA) 
12-24 Month Price Target $9.25

Allocation 5

Summit recently completed a secondary offering of roughly 4.1 million shares at $1.33 per share for gross proceeds of about $5.4 million. We are pleased that they were able to put some additional needed working capital in the bank, although we were not particularly happy about the pricing it was done at. We won’t re-beat the dead horse, but as we have noted many times, for small emerging companies like Summit that are dependent on equity raises until they can advance the business to positive cash flow, the specter of unknown amounts of additional dilution can provide significant headwinds for share prices. Below is some narrative we provided in our recent conference overview of the Company, that we think is still germane and provides a good backdrop for our allocation increase: We commenced coverage of Summit in September 2018 with a 12-24 month price target of $9.25.  Click Here for Complete Report

 

Donald Capital, LLC, A New Investment Bank Opens Its Doors

NEW YORK, May 16, 2019 (GLOBE NEWSWIRE) – Donald Capital, LLC has launched today as a FINRA member Investment Bank. Founded with the intent to build a legacy based upon the fundamentals of honesty and integrity.

Donald Capital will focus on a market that has not been properly served for some time – the Private, Micro, Small & Mid Cap Markets. 

Co-founders Alex Hamilton and Don McDonald have launched several initiatives over their extensive careers to serve this part of the market.  They are very familiar with the challenges facing companies in this market and have the unique perspective to provide solutions.  Read Complete Press Release

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

 

July-24-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

 

 

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

04/06/18

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

 

 

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  07-10/19

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

 

 

  06/04/19

News

Social Reality, Inc. (SRAX)

 

 

02/05/19

News

 

 

 

 

July 29th, 2019

ValuEngine Weekly Report

By: Paul Henneman

ValuEngine Market Valuation update for the week of July 26, 2019. Stock pick of the week is ticker NVCR (Novocure LTD). The overall number of undervalued stocks versus overvalued continues to slowly fall, but a slight majority remain undervalued. Read the full blog post for updated sector valuations, stock pick, and more.

Read on for more and full updated market/sector numbers for the week.

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.

Read Complete Report

 

Categories Uncategorized, Weekly NewsletterTags market valuations, markets, sector, sector valuations, sectors, stock market, stock pick, STRONG BUY, STRONG BUY stocks, valuations, valuengine, ZNGA, Zynga

VALUATION WATCH: Overvalued stocks now make up 35.94% of our stocks assigned a valuation and 12.85% of those equities are calculated to be overvalued by 20% or more.

 

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

 

Black Swan Research Coverage and Subscription Service
Click Here>>

 

Event Calendar Updates

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.
Click Here for Details

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

This post has not been tagged.

Share |
PermalinkComments (0)
 

Stock Market Manager Weekly Update: July 24th, 2019

Posted By Administration, Friday, July 26, 2019

SMM Logo

               

 

 

 

Weekly Update: July 24th, 2019

http://www.valuengine.com/images/newsletter/weekly/facebook-icon-743200.jpg

http://www.valuengine.com/images/newsletter/weekly/TWITTERICON.jpg

http://ecomallymail.com/uploads/1524105419.png

6,462

520

472

6

11

 

 

Black Swan Connection Newsletter Signup


Breaking News

Investopia July-25-19

CEO Musk's Dream Is Fading As Tesla Losses Mount

Many Tesla Inc. (TSLA) investors for years have forecasted that the electric car maker led by CEO Elon Musk would finally enter a path of sustained profitability. Instead, Tesla reported a loss of $1.12 per share, far bigger than any analyst had expected, Bloomberg reports. If that were not enough, CEO Musk announced during his earnings call that J.B. Straubel, Tesla's chief technical officer (CTO), is leaving that position to become an "adviser" to the company.

Read Complete Article

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report

 

7-10-19 Endurance Exploration Group, Inc. (EXPL)
BWVI and EXPL Continue to Work Through 2019 Season

Jacksonville FL, July 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (BWVI) and project partner Endurance Exploration Group, Inc. (EXPL), are well into the 2019 recovery season on the SB Pulaski.   The SB Pulaski sank in 1838 while in route from Savannah, Georgia to Baltimore, Maryland.  She carried some of the South’s wealthiest families.  The shipwreck was considered the “Titanic” of its’ day.  

The Blue Water Rose has been based out of Wrightsville Beach, North Carolina since mid June.  As weather permits, on site excavations have continued with the recovery of more silver and copper coins; most from US origins, a small gold pocket watch, silver ware and wreck material.  A more detailed survey of bottom conditions has shown Hurricane Florence (September 2018) had a bigger impact on the seabed than was earlier believed.   The Blue Water dive team will continue with a methodical recovery plan to ensure that the entire wreck area will be thoroughly recorded and searched.  Keith Webb, President of Blue Water Ventures International, states, “We are very encouraged with the magnetometer results that were conducted in June and have now established the debris line which should unlock the Pulaski’s secrets.” 

Read Complete Press Release

 

6-12-19 Canbiola, Inc. (CANB)
Canbiola Presentation from Annual Shareholder Meeting is Publicly Available

HICKSVILLE, NY, July 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola,Inc. (OTCQB: CANB)(“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that its presentation from its Annual Shareholder Meeting held on Friday, June 14, is now publicly available.

We encourage you to read the filing at:

https://www.sec.gov/Archives/edgar/data/1509957/000149315219009362/0001493152-19-009362-index.htm

Canbiola Chief Executive Officer Marco Alfonsi commented, “We want to thank all of our shareholders, especially the 100+ that attended our meeting a couple of weeks ago. Our entire team was thrilled with the turn out and enthusiasm.

Read Complete Press Release

 

6-12-19 Canbiola, Inc. (CANB)
Canbiola and Shi Farms Execute Letter of Intent to Form Joint Venture for Hemp Cultivation & Processing

Plans to Open a NY Depot for Hemp Cultivation

HICKSVILLE, NY, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that has entered into a non-binding Letter of Intent (the “LOI”) with Shi Farms, Inc. (“Shi Farms”), a licensed Hemp Cultivation Operation under the Colorado Department of Agriculture, operating a 300-acre farm and 40,000 square feet of research greenhouses to grow, cultivate, accumulate and process hemp in New York State under a license from Shi Farms. 

For more information about Shi Farms, please visit: https://www.shifarms.com.

Read Complete Press Release

 

6-6-2019 Greenridge Global Equity Research Issues Update Guangdong Land Holdings, Ltd. HKSE 0124
Maintaining rating and Buy target HK$ 4.75

Hou Wailin Joins GDL As Chairman Of The Board

Hou Wailin Joins GDL as Chairman of the Board.  Effective yesterday, June 5, Chairman Huang Xiaofeng tendered his resignation as Non-Executive Director and Chairman of the Board after reaching his retirement age.  Chairman Huang served in these positions for roughly ten years and oversaw the transition from Kingway Brewery to a real estate development firm.  Concurrent with this announcement, Mr. Hou Wailin was appointed Non-Executive Director and Chairman of the Board.  Mr. Hou was appointed Chairman of Guangdong Holdings and GDH Limited, the ultimate parent companies of GDL, in May 2019.  Previous experience includes serving as Chairman of Guangdong Technology Financial Group and as Director-General of Guangdong Regulatory Bureau of the China Securities Regulatory Commission (“CSRC”) and Chief Inspector of the General Inspection Taskforce of CSRC.  Similar to Chairman Huang, Chairman Hou will not receive any compensation for this position.  We do not expect any significant shifts in the direction of GDL with this change.

AGM Today.  The AGM will be held later today (June 6, 2019) at 3pm in the Concord Room of the Renaissance Hotel in Wan Chai.

Model Update.  We have made no changes to our model as we expect a continuation of the current business model.

Maintaining Rating & Target.  With no changes to our model we are reiterating our Buy rating and HK$4.75 target price on Guangdong Land.  We continue to believe the current share price does not accurately reflect the underlying value of the Company’s real estate portfolio or the GDH City project.  Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.

Read Complete Report

 

 6-4-19 Trickle Research Issues Allocation Update Report
Summit Wireless Technologies, Inc.  Nasdaq (WISA) 
12-24 Month Price Target $9.25

Allocation 5

Summit recently completed a secondary offering of roughly 4.1 million shares at $1.33 per share for gross proceeds of about $5.4 million. We are pleased that they were able to put some additional needed working capital in the bank, although we were not particularly happy about the pricing it was done at. We won’t re-beat the dead horse, but as we have noted many times, for small emerging companies like Summit that are dependent on equity raises until they can advance the business to positive cash flow, the specter of unknown amounts of additional dilution can provide significant headwinds for share prices. Below is some narrative we provided in our recent conference overview of the Company, that we think is still germane and provides a good backdrop for our allocation increase: We commenced coverage of Summit in September 2018 with a 12-24 month price target of $9.25.

Click Here for Complete Report

Donald Capital, LLC, A New Investment Bank Opens Its Doors

NEW YORK, May 16, 2019 (GLOBE NEWSWIRE) – Donald Capital, LLC has launched today as a FINRA member Investment Bank. Founded with the intent to build a legacy based upon the fundamentals of honesty and integrity.

Donald Capital will focus on a market that has not been properly served for some time – the Private, Micro, Small & Mid Cap Markets. 

Co-founders Alex Hamilton and Don McDonald have launched several initiatives over their extensive careers to serve this part of the market.  They are very familiar with the challenges facing companies in this market and have the unique perspective to provide solutions.

Read Complete Press Release

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

July-24-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

04/06/18

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  07-10/19

News

FULLSHARE HOLDINGS LTD. (607) HK

 

09/07/18

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 

 


 

 

July 19th, 2019

ValuEngine Weekly Report

By: Paul Henneman

ValuEngine Market Valuation update for the week of July 19, 2019. Stock pick of the week is ticker GLPG (Galapagos-ADR). It is a biotech company with a big increase in stock price since ValuEngine first updgraded it to a Strong Buy in mid 2018. There still may be some upside, although riskier now. Read on for more and full updated market/sector numbers for the week.

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.

Read Complete Report

 

Categories Uncategorized, Weekly NewsletterTags market valuations, markets, sector, sector valuations, sectors, stock market, stock pick, STRONG BUY, STRONG BUY stocks, valuations, valuengine, ZNGA, Zynga

VALUATION WATCH: Overvalued stocks now make up 35.94% of our stocks assigned a valuation and 12.85% of those equities are calculated to be overvalued by 20% or more.

 

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

 

Black Swan Research Coverage and Subscription Service
Click Here>>

 

Event Calendar Updates

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.

Click Here for Details

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

This post has not been tagged.

Share |
PermalinkComments (0)
 

Black Swan Connection July 2019

Posted By Administration, Friday, July 19, 2019

July 2019

                

 6,462     1,414       472         8           6


Our goal with the Black Swan Connection is to provide our subscribers, investors and financial professional compatriots outstanding investment insight that is a step above and outside of what will normally be found in mainstream financial press. To that end we have brought together seasoned, successful, and some of the brightest professionals in their respective fields to provide the articles and advice that is based on decades of practice in the field.

Black Swan Connection Newsletter Signup

 

Breaking News

The Street July 16-2019

What Jim Cramer's Paying Attention to in JPMorgan Chase's Earnings Report

Earnings season has officially kicked off. 

Tuesday morning saw earnings from banks such as Real Money stock of the day JPMorgan Chase (JPM - Get Report) and Goldman Sachs (GS - Get Report) . 

JPMorgan reported that net income in the quarter rose by 16% to $9.65 billion. The company announced earnings per share at $2.82, which beat the $2.50 average EPS estimate that analysts expected, according to FactSet.

See Report

 

Feature Article

July 2019

The Unintended Consequences of Chaos

By: Dave Lavigne

It’s fascinating how sometimes seemingly unrelated things create a web of complexities that ultimately demonstrate how interrelated things might actually be. I think that notion falls into the guise of Chaos Theory or at least some portion of it.

Just to edify, www.fractalfoundation.org defines Chaos Theory as follows:

“Chaos is the science of surprises, of the nonlinear and the unpredictable. It teaches us to expect the unexpected. While most traditional science deals with supposedly predictable phenomena like gravity, electricity, or chemical reactions, Chaos Theory deals with nonlinear things that are effectively impossible to predict or control, like turbulence, weather, the stock market, our brain states, and so on. These phenomena are often described by fractal mathematics, which captures the infinite complexity of nature. Many natural objects exhibit fractal properties, including landscapes, clouds, trees, organs, rivers etc, and many of the systems in which we live exhibit complex, chaotic behavior. Recognizing the chaotic, fractal nature of our world can give us new insight, power, and wisdom. For example, by understanding the complex, chaotic dynamics of the atmosphere, a balloon pilot can “steer” a balloon to a desired location. By understanding that our ecosystems, our social systems, and our economic systems are interconnected, we can hope to avoid actions which may end up being detrimental to our long-term well-being”.  

As an adjunct to the above, some may be more familiar with one of Chaos’s often used examples:  “Does the flap of a butterfly’s wings in Brazil set off a tornado in Texas”?

Read Complete Article

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report

 

 6-6-2019 Greenridge Global Equity Research Issues Update Guangdong Land Holdings, Ltd. HKSE 0124
Maintaining rating and Buy target HK$ 4.75

Hou Wailin Joins GDL As Chairman Of The Board

Hou Wailin Joins GDL as Chairman of the Board.  Effective yesterday, June 5, Chairman Huang Xiaofeng tendered his resignation as Non-Executive Director and Chairman of the Board after reaching his retirement age.  Chairman Huang served in these positions for roughly ten years and oversaw the transition from Kingway Brewery to a real estate development firm.  Concurrent with this announcement, Mr. Hou Wailin was appointed Non-Executive Director and Chairman of the Board.  Mr. Hou was appointed Chairman of Guangdong Holdings and GDH Limited, the ultimate parent companies of GDL, in May 2019.  Previous experience includes serving as Chairman of Guangdong Technology Financial Group and as Director-General of Guangdong Regulatory Bureau of the China Securities Regulatory Commission (“CSRC”) and Chief Inspector of the General Inspection Taskforce of CSRC.  Similar to Chairman Huang, Chairman Hou will not receive any compensation for this position.  We do not expect any significant shifts in the direction of GDL with this change.

AGM Today.  The AGM will be held later today (June 6, 2019) at 3pm in the Concord Room of the Renaissance Hotel in Wan Chai.

Model Update.  We have made no changes to our model as we expect a continuation of the current business model.

Maintaining Rating & Target.  With no changes to our model we are reiterating our Buy rating and HK$4.75 target price on Guangdong Land.  We continue to believe the current share price does not accurately reflect the underlying value of the Company’s real estate portfolio or the GDH City project.  Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.

Read Complete Report

 

 6-4-19 Trickle Research Issues Allocation Update Report
Summit Wireless Technologies, Inc.  Nasdaq (WISA) 
12-24 Month Price Target $9.25

Allocation 5

2Summit recently completed a secondary offering of roughly 4.1 million shares at $1.33 per share for gross proceeds of about $5.4 million. We are pleased that they were able to put some additional needed working capital in the bank, although we were not particularly happy about the pricing it was done at. We won’t re-beat the dead horse, but as we have noted many times, for small emerging companies like Summit that are dependent on equity raises until they can advance the business to positive cash flow, the specter of unknown amounts of additional dilution can provide significant headwinds for share prices. Below is some narrative we provided in our recent conference overview of the Company, that we think is still germane and provides a good backdrop for our allocation increase: We commenced coverage of Summit in September 2018 with a 12-24 month price target of $9.25.

Click Here for Complete Report

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

 

SMM Coverage-Special Situations

Elio Motors, Inc. (ELIO) $1.42 7-18-19

Petition for class action lawsuit
 

SHORT- Elio Motors, Inc. –ELIO Nov-2016  $11.80  Dec 17-18 price $3.15 starting to slip slide away again. (nice chance to add to short if you can get a borrow on ELIO).  Last news was almost 5 months ago from company. Still on perpetual begathon for new reservations. Still needs $300 million plus another $545,000 to cover this fine, but reality is that this car cannot be built for the price he talks about.

Nothing new in SEC Filings and no news now for 7 months- That’s NOT good news

Posted by u/snugglesdog

Petition to file class action lawsuit against Elio Motors

This is a petition to file a class action lawsuit against Elio Motors. They keep accepting reservations for cars but they have no problem delaying and pushing back the release date of the vehicle. This petition should at the very least, garner enough support to initiate a class action lawsuit that allows customers to get their reservation cost back immediately or in the near future. Should the release date be pushed back yet another time, I suggest some sort of government interference to either shutdown or temporarily prevent their ability to collect funds from more unsuspecting buyers.

Sign up here

Won’t be long now..

Beginning of the end… Hope Paul saved up some bail money, that’s coming next in this 3 wheel ponzi scheme…

 

July-19 MODEL PORTFOLIO FOR TRICKLE RESEARCH, LLC.:

 

Initiation

 

Price

Initiation

Price @

 

Stock

Symbol

Date

Allocation

Target

Cost Px.

7/16/2019

 

SRAX (Social Reality)

SRAX

Multiple

5

$15.00

$1.79

$4.71

 

Pure Cycle

PCYO

5/5/17

3

$12.00

$7.60

$10.89

 

Command Center

CCNI

9/8/17

5

$8.75

$4.44

$5.84

 

Endurance Exploration

EXPL

11/6/17

3

$0.29

$0.18

$0.12

 

Assure Holdings Corp.

ARHH

11/10/17

5

$6.00

$2.90

$1.20

 

AzurRx BioPharma

AZRZ

2/7/18

7

$10.25

$2.96

$1.10

 

Camino Minerals, Corp

CAMZF

4/6/18

4

$0.90

$0.26

$0.09

 

PetroShare Corp

PRHR

5/31/18

5

$2.65

$1.44

$0.19

 

Gold Resource Corp

GORO

7/30/18

5

$7.35

$6.49

$3.45

 

Summit Wirelss

WISA

9/28/18

5

$9.25

$4.30

$1.10

 

Alvoperto Energy, Ltd.

ALVOF

11/7/18

5

$1.10

$0.39

$0.64

 

SG Blocks

SGBX

2/28/19

5

$6.25

$2.84

$0.86

 

H-Source Holdings

HSCHF

4/9/19

4

$0.19

$.06

$0.04

 

 

 

Initiation

 Termination 

 

Price

Initiation

Termination

Terminated Coverage

Symbol

Date

Date

Allocation

Target

Price

Price

ID Watchdog

IDW

10/13/16

8/28/2017

4

$0.42

$0.14

$0.40

GrowGeneration

GRWG

6/20/17

12/21/17

4

$3.40

$2.00

       $3.44  

Barfresh Food Group

BRFH

 

8/20/18

1

 

$0.55

$0.53

Semler Scientific

SMLR

12/27/17

11/7/18

    4

$15.00

$8.00

$31.99

New Jersey Mining

NJMC

4-18

5/16/19

           3

$0.30

$0.12

$1.31

 

 

 

 

 

 

 

 

 

 

For complete details and assumptions please see the assumptions and explanations document Click Here

 

 

For a review and details on 2017 performance and model portfolio assumptions  Click Here

 

 

*Please note Dave Lavigne in the principal in Trickle Research and is also the editor of the Black Swan Connection Newsletter and an ongoing contributor to SMM.

 

July 18-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

04/06/18

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  03-26/19

News

FULLSHARE HOLDINGS LTD. (607) HK

 

09/07/18

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 

 

Go to ValuEngine.com

    
 

July 15th, 2019  by Paul Henneman

ValuEngine Market Valuation update for the week of July 12, 2019. Stock pick of the week is ticker GOL (Gol Linhas-ADR). Roughly 62% of about 4,000 stocks covered remain undervalued. All sector valuations updated.

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.

VALUATION WATCH: Overvalued stocks now make up 37.89% of our stocks assigned a

valuation and 14.72% of those equities are calculated to be overvalued by 20% or more.

Read Full Report

 

 

SMM Research Subscription Service.
Black Swan Research

Subscribers will get Real Time notification as Research Reports and updates are available as well as latest press releases and news on the companies covered.

Black Swan Research coverage is a compilation of some of the best independent providers of Micro Cap Research.  The service focuses on micro-cap companies that are typically not followed by Wall Street analysts.  In addition our subscription research service includes ValuEngine research on over 5,000 stocks with stock valuations, Buy/Hold/Sell recommendations, and forecasted target prices.

 Click Here for Complete Description

See Below for current coverage and info regarding our Research providers

Trickle Research Click Here for More info>>

*Research on the following companies is available to BS Research or Trickle research subscribers only

  • Pure Cycle (PCYO)  -
  • Semler Scientific, Inc. (SMLR)

Greenridge Global, LLC Click Here for More Info>>

ValuEngine Click Here for More Info >>

ValuEngine.com (VE) is a stock valuation and forecasting service founded by Ivy League finance academics. VE utilizes the most advanced quantitative techniques and analysis available.

To Subscribe Please click Here
 

 

Reg A or D 506(c)

If you have a Reg A or 506(c) offering you would like us to distribute to our database, please give us a ring or email to:
727-823-3987
cdilley@smm.global


Event Calendar Updates

Summer doldrums- Nothing coming up immediately

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.

Click Here for Details


Carl Dilley
cdilley@smm.global

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)       1,414

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                                0

Direct Email     *                                                          249,000

Total                                                                           257,354

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

This post has not been tagged.

Share |
PermalinkComments (0)
 

Stock Market Manager Weekly Update: July 10th, 2019

Posted By Administration, Thursday, July 11, 2019

SMM Logo

               

 

 

 

Weekly Update: July 10th, 2019

http://www.valuengine.com/images/newsletter/weekly/facebook-icon-743200.jpg

http://www.valuengine.com/images/newsletter/weekly/TWITTERICON.jpg

http://ecomallymail.com/uploads/1524105419.png

6,462

520

472

6

11

 

 

Black Swan Connection Newsletter Signup


Breaking News

 

Ben Walsh-Barrons July-10-19

The Dow Is Up 90 Points Because an Interest-Rate Cut Looks Even More Likely

Dovish gains. U.S. stocks rose after Federal Reserve Chairman Jerome Powell upped investors’ expectations for a interest-rate cut later this month, saying in prepared remarks to Congress that global economic weakness is hitting the U.S. economy.

The Dow Jones Industrial Average gained 90 points, or 0.3%. The S&P 500 index briefly hit a record by passing the 3,000 mark, before receding to a gain of 0.5%. The Nasdaq Composite rose 0.7%.

Midday Movers

Three of the top four gainers were technology companies, with Micron Technology (ticker: MU) up 3.9%, Western Digital (WDC) up 3.6%, and Seagate Technologies (STX) up 3% after Taiwan Semiconductor Manufacturing said its revenue for June climbed 22% compared with last year.

Read Complete Article

 

7-10-19 Endurance Exploration Group, Inc. (EXPL)
BWVI and EXPL Continue to Work Through 2019 Season

Jacksonville FL, July 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (BWVI) and project partner Endurance Exploration Group, Inc. (EXPL), are well into the 2019 recovery season on the SB Pulaski.   The SB Pulaski sank in 1838 while in route from Savannah, Georgia to Baltimore, Maryland.  She carried some of the South’s wealthiest families.  The shipwreck was considered the “Titanic” of its’ day.  

The Blue Water Rose has been based out of Wrightsville Beach, North Carolina since mid June.  As weather permits, on site excavations have continued with the recovery of more silver and copper coins; most from US origins, a small gold pocket watch, silver ware and wreck material.  A more detailed survey of bottom conditions has shown Hurricane Florence (September 2018) had a bigger impact on the seabed than was earlier believed.   The Blue Water dive team will continue with a methodical recovery plan to ensure that the entire wreck area will be thoroughly recorded and searched.  Keith Webb, President of Blue Water Ventures International, states, “We are very encouraged with the magnetometer results that were conducted in June and have now established the debris line which should unlock the Pulaski’s secrets.” 

Read Complete Press Release

 

6-12-19 Canbiola, Inc. (CANB)
Canbiola Presentation from Annual Shareholder Meeting is Publicly Available

HICKSVILLE, NY, July 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola,Inc. (OTCQB: CANB)(“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that its presentation from its Annual Shareholder Meeting held on Friday, June 14, is now publicly available.

We encourage you to read the filing at:

https://www.sec.gov/Archives/edgar/data/1509957/000149315219009362/0001493152-19-009362-index.htm

Canbiola Chief Executive Officer Marco Alfonsi commented, “We want to thank all of our shareholders, especially the 100+ that attended our meeting a couple of weeks ago. Our entire team was thrilled with the turn out and enthusiasm.

Read Complete Press Release

 

6-12-19 Canbiola, Inc. (CANB)
Canbiola and Shi Farms Execute Letter of Intent to Form Joint Venture for Hemp Cultivation & Processing

Plans to Open a NY Depot for Hemp Cultivation

HICKSVILLE, NY, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that has entered into a non-binding Letter of Intent (the “LOI”) with Shi Farms, Inc. (“Shi Farms”), a licensed Hemp Cultivation Operation under the Colorado Department of Agriculture, operating a 300-acre farm and 40,000 square feet of research greenhouses to grow, cultivate, accumulate and process hemp in New York State under a license from Shi Farms. 

For more information about Shi Farms, please visit: https://www.shifarms.com.

Read Complete Press Release

 

 6-6-2019 Greenridge Global Equity Research Issues Update Guangdong Land Holdings, Ltd. HKSE 0124
Maintaining rating and Buy target HK$ 4.75

Hou Wailin Joins GDL As Chairman Of The Board

Hou Wailin Joins GDL as Chairman of the Board.  Effective yesterday, June 5, Chairman Huang Xiaofeng tendered his resignation as Non-Executive Director and Chairman of the Board after reaching his retirement age.  Chairman Huang served in these positions for roughly ten years and oversaw the transition from Kingway Brewery to a real estate development firm.  Concurrent with this announcement, Mr. Hou Wailin was appointed Non-Executive Director and Chairman of the Board.  Mr. Hou was appointed Chairman of Guangdong Holdings and GDH Limited, the ultimate parent companies of GDL, in May 2019.  Previous experience includes serving as Chairman of Guangdong Technology Financial Group and as Director-General of Guangdong Regulatory Bureau of the China Securities Regulatory Commission (“CSRC”) and Chief Inspector of the General Inspection Taskforce of CSRC.  Similar to Chairman Huang, Chairman Hou will not receive any compensation for this position.  We do not expect any significant shifts in the direction of GDL with this change.

AGM Today.  The AGM will be held later today (June 6, 2019) at 3pm in the Concord Room of the Renaissance Hotel in Wan Chai.

Model Update.  We have made no changes to our model as we expect a continuation of the current business model.

Maintaining Rating & Target.  With no changes to our model we are reiterating our Buy rating and HK$4.75 target price on Guangdong Land.  We continue to believe the current share price does not accurately reflect the underlying value of the Company’s real estate portfolio or the GDH City project.  Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.

Read Complete Report

 

 6-4-19 Trickle Research Issues Allocation Update Report
Summit Wireless Technologies, Inc.  Nasdaq (WISA) 
12-24 Month Price Target $9.25

Allocation 5

2Summit recently completed a secondary offering of roughly 4.1 million shares at $1.33 per share for gross proceeds of about $5.4 million. We are pleased that they were able to put some additional needed working capital in the bank, although we were not particularly happy about the pricing it was done at. We won’t re-beat the dead horse, but as we have noted many times, for small emerging companies like Summit that are dependent on equity raises until they can advance the business to positive cash flow, the specter of unknown amounts of additional dilution can provide significant headwinds for share prices. Below is some narrative we provided in our recent conference overview of the Company, that we think is still germane and provides a good backdrop for our allocation increase: We commenced coverage of Summit in September 2018 with a 12-24 month price target of $9.25.

Click Here for Complete Report

 

Donald Capital, LLC, A New Investment Bank Opens Its Doors

NEW YORK, May 16, 2019 (GLOBE NEWSWIRE) – Donald Capital, LLC has launched today as a FINRA member Investment Bank. Founded with the intent to build a legacy based upon the fundamentals of honesty and integrity.

Donald Capital will focus on a market that has not been properly served for some time – the Private, Micro, Small & Mid Cap Markets. 

Co-founders Alex Hamilton and Don McDonald have launched several initiatives over their extensive careers to serve this part of the market.  They are very familiar with the challenges facing companies in this market and have the unique perspective to provide solutions.

Read Complete Press Release

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

July-10-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

02/26/19

News

Camino Minerals Corp. (CAMZF)

 

04/06/18

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  07-10/19

News

FULLSHARE HOLDINGS LTD. (607) HK

 

09/07/18

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 

 

 

 

July 5th, 2019

ValuEngine Weekly Report

By: Paul Henneman

 

ValuEngine Market Valuation update for the week of June 28, 2019. Stock pick of the week is ticker SRPT (Sarepta Therapeutics Inc). There has been some changes in overall Sector group valuations, read on for updated numbers.

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.

Read Complete Report


 

Categories Uncategorized, Weekly NewsletterTags market valuations, markets, sector, sector valuations, sectors, stock market, stock pick, STRONG BUY, STRONG BUY stocks, valuations, valuengine, ZNGA, Zynga

VALUATION WATCH: Overvalued stocks now make up 35.94% of our stocks assigned a valuation and 12.85% of those equities are calculated to be overvalued by 20% or more.

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

 

Black Swan Research Coverage and Subscription Service
Click Here>>

 

Event Calendar Updates

Summer doldrums- Nothing coming up immediately

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.

Click Here for Details

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

This post has not been tagged.

Share |
PermalinkComments (0)
 
Page 1 of 12
1  |  2  |  3  |  4  |  5  |  6  >   >>   >| 
Community Search
Sign In


Calendar

The upcoming calendar is currently empty.

Click here to view past events and photos »